Mersana Therapeutics Inc (NASDAQ:MRSN) shares, rose in value, with the stock price down by -4.49% to the previous day’s close as strong demand from buyers drove the stock to $4.25.
Actively observing the price movement in the last trading, the stock closed the session at $4.45. The value of beta (5-year monthly) was 1.51. Referring to stock’s 52-week performance, its high was $9.62, and the low was $0.80. On the whole, MRSN has fluctuated by -26.34% over the past month.
With the market capitalization of Mersana Therapeutics Inc currently standing at about $515.52 million, investors are eagerly awaiting this quarter’s results, scheduled for May 07, 2024 – May 13, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.18, which is expected to increase to -$0.13 for fiscal year -$0.66 and then to about -$0.72 by fiscal year 2025. Data indicates that the EPS growth is expected to be 55.40% in 2025, while the next year’s EPS growth is forecast to be -9.10%.
According to the average forecast, sales growth in current quarter could jump up 1.60%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $37.69 million, representing an increase of 2.30% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that MRSN’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of 50% Buy while long term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of MRSN currently trading nearly -14.39% and -2.27% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 41.90, while the 7-day volatility ratio is showing 7.65% which for the 30-day chart, stands at 8.41%. Furthermore, Mersana Therapeutics Inc (MRSN)’s beta value is 1.51, and its average true range (ATR) is 0.40.
Data on historical trading for Mersana Therapeutics Inc (NASDAQ:MRSN) indicates that the trading volumes over the past 10 days have averaged 1.85 million and over the past 3 months, they’ve averaged 2.38 million. According to company’s latest data on outstanding shares, there are 120.71 million shares outstanding.
Nearly 24.32% of Mersana Therapeutics Inc’s shares belong to company insiders and institutional investors own 71.08% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 8.73 million shares as on Mar 15, 2024, resulting in a short ratio of 3.03. According to the data, the short interest in Mersana Therapeutics Inc (MRSN) stood at 7.19% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 7.1 million. The stock has risen by 83.19% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MRSN stock heading into the next quarter.
